TAG:
pathology test
March 17, 2014 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XXI No. 4 – March 17, 2014 Issue
People walking down a street in Weatherford, Connecticut on March 10, found lab test reports for at least 16 patients, according to a news report by a local television news station. This is a breach of protected health information (PHI) under the federal HIPAA statute. Reporters from WSFB contacted o…
Across the Pond, Lots of Changes in Lab Testing
By R. Lewis Dark | From the Volume XXI No. 2 – February 3, 2014 Issue
IN BOTH THE UNITED KINGDOM AND EUROPE, plenty of change is unfolding in clinical laboratory and anatomic pathology testing. Our intrepid Editor-in-Chief, Robert L. Michel, spent last week in England attending our annual Frontiers in Laboratory Medicine conference, now in its eleventh year. …
Quality Assurance Regs to Tighten for UK Labs
By Robert Michel | From the Volume XXI No. 2 – February 3, 2014 Issue
CEO SUMMARY: In the United Kingdom, a window of opportunity has opened for improving the quality assurance activities of pathology and histopathology laboratories. Last week, at the Frontiers in Laboratory Medicine conference, the newly-published “Pathology Quality Assurance Review” w…
Medicare OPPS Rule Has Pitfalls for Labs
By Joseph Burns | From the Volume XXI No. 2 – February 3, 2014 Issue
CEO SUMMARY: On January 1, the new Medicare rule for requiring bundled or packaged reimbursement for certain services covered by the hospital Outpatient Prospective Payment System (OPPS) became effective. Just four days earlier (on December 27), Medicare officials issued instructions on h…
Tricare, DOD Not Paying for MoPath Codes, LDTs
By Joseph Burns | From the Volume XXI No. 1 – January 13, 2014 Issue
CEO SUMMARY: It turns out that labs serving Tricare patients are going unpaid for certain LDTs, molecular, and genetic tests. The issue of nonpayment began in January 2013 when Tricare stopped paying for these tests that were billed under the new molecular CPT codes that replaced the prev…
Tennessee BCBS Cuts Lab Fees to 52% of Medicare
By Joseph Burns | From the Volume XX, No. 17 – December 23, 2013 Issue
CEO SUMMARY: Blue Cross Blue Shield of Tennessee has notified physicians that, starting January 1, it will reduce what it pays for lab testing to 52% of Medicare fees. Officials with the state medical association have been unable to get definitive answers to questions about what tests wou…
ACLA, CAP Comment on Final 2014 Medicare Rules
By Joseph Burns | From the Volume XX, No. 16 – December 2, 2013 Issue
CEO SUMMARY: On November 27, as the nation prepared for the Thanksgiving holiday, the federal Centers for Medicare & Medicaid Services (CMS) announced the long-awaited final rules for 2014. Early analysis of the 1,300 pages of rules CMS released indicates that the agency moderated one…
Medicare Price Cuts Drive Labs to Sell or File BK
By Robert Michel | From the Volume XX No. 15 – November 11, 2013 Issue
CEO SUMMARY: Professional investors are smart with their money. Thus, it is no surprise that clinical lab and pathology companies owned by private equity firms are the first to be sold or closed. These investors are acting in response to the cumulative negative financial impact of recent …
Most Colorado Labs Now Connected to State’s HIE
By Robert Michel | From the Volume XX No. 15 – November 11, 2013 Issue
CEO SUMMARY: One trend getting little publicity is that of health information exchanges (HIEs). Since its founding in 2009, the Colorado Regional Health Information Organization (CORHIO) has grown steadily. Today, most of the state’s independent lab companies and hospital laboratories a…
Attention Pathologists: Change Is Coming!
By R. Lewis Dark | From the Volume XX No. 13 – September 30, 2013 Issue
IT’S BEEN A BUSY FOUR WEEKS for your editor at THE DARK REPORT. He has traveled to meetings, conducted site visits at a variety of large and small companies serving clinical labs and pathology groups, and even participated in strategic planning sessions for some labs and industry vendors. I asked …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized